IRIS
GAUDIO, AGOSTINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.099
EU - Europa 957
AS - Asia 278
SA - Sud America 5
OC - Oceania 1
Totale 2.340
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.097
IE - Irlanda 326
SE - Svezia 306
CN - Cina 195
DE - Germania 85
IT - Italia 72
UA - Ucraina 60
FI - Finlandia 37
SG - Singapore 35
HK - Hong Kong 26
GB - Regno Unito 21
FR - Francia 17
IN - India 17
BE - Belgio 13
PL - Polonia 9
CZ - Repubblica Ceca 5
CL - Cile 3
NL - Olanda 3
BR - Brasile 2
CA - Canada 2
KR - Corea 2
RU - Federazione Russa 2
AT - Austria 1
AU - Australia 1
IR - Iran 1
JP - Giappone 1
VN - Vietnam 1
Totale 2.340
Salva come PNG Salva come JPEG
Città #
Dublin 326
Chandler 239
Nyköping 172
Jacksonville 146
Beijing 67
Ashburn 64
New York 50
Princeton 47
Medford 44
Ann Arbor 37
Dearborn 34
Des Moines 31
Cambridge 30
Boardman 29
Bremen 29
Shenyang 22
Singapore 20
Messina 18
Jinan 15
Nanjing 15
Brussels 13
Munich 13
Wilmington 13
Helsinki 11
Pune 11
Tianjin 11
Seattle 10
Houston 9
San Mateo 9
Warsaw 9
Hebei 8
Lancaster 8
Central 7
Sheung Shui 7
Strasbourg 7
Falls Church 6
Hangzhou 6
Los Angeles 6
Woodbridge 6
Brno 5
Fuzhou 5
Haikou 5
Taiyuan 5
Zhengzhou 5
Guangzhou 4
Nanchang 4
Clearwater 3
Hyderabad 3
Leawood 3
Ningbo 3
Norwalk 3
Paterno 3
Polverigi 3
Rho 3
Sheffield 3
Taizhou 3
Auburn Hills 2
Bari 2
Cairo Montenotte 2
Catania 2
Changsha 2
Fiumefreddo Di Sicilia 2
Itasca 2
Jeffries 2
Lanzhou 2
Lappeenranta 2
Milan 2
Muespach 2
Nuremberg 2
Regalbuto 2
Santa Clara 2
Santiago 2
Scandicci 2
Turin 2
Washington 2
Ardabil 1
Augusta 1
Biancavilla 1
Buffalo Grove 1
Chaoyang 1
Chicago 1
Cupertino 1
Den Haag 1
Edinburgh 1
Fremont 1
Hanover 1
Hefei 1
Ho Chi Minh City 1
Milazzo 1
Monmouth Junction 1
Mountain View 1
Mumbai 1
Novokuznetsk 1
Ottawa 1
Reno 1
Riva 1
Rome 1
Tappahannock 1
Tomsk 1
Vancouver 1
Totale 1.731
Salva come PNG Salva come JPEG
Nome #
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 85
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 84
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin 82
AB0819 HANDGRIP STRENGTH PREDICTS HIGH FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 73
BONE MASS AND BONE TURNOVER IN WOMEN WITH THALASSEMIA MAJOR RELATED OSTEOPOROSIS: EFFECTS OF STRONTIUM RANELATE 69
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 68
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 66
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 61
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 61
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 60
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 60
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 59
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 59
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 58
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 58
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 58
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 58
EFFECTS OF DENOSUMAB ON QUATITATIVE ULTRASOUND AND DXA MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 57
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 56
CORRELATION BETWEEN FAMILY HISTORY OF HYPERTENSION AND HAEMOSTATIC DISORDERS 52
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 52
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 51
Hemostasis and fibrinolysis factors in first-degree relatives of patients with type 2 diabetes without hypertension 50
Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major 50
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 50
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 49
Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women 49
HANDGRIP STRENGTH TO DISCRIMINATE HIGH FRACTURE RISK IN TYPE 2 DIABETES MELLITUS PATIENTS 49
Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors 48
Effetti del raloxifene sulla secrezione ipofisaria in post-menopausa 46
ALENDRONATE TAIL EFFECT ON BONE IS MODULATED BY VITAMIN D: A RETROSPECTIVE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS 42
VITAMIN D PROMOTES BONE MINERAL DENSITY ACCRUAL AFTER DISCONTINUATION OF ALENDRONATE 41
Pharmacological management of severe postmenopausal osteoporosis 40
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: New pieces of the puzzle 40
Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D 40
Menopause modulates homocysteine levels in diabetic and non-diabetic women. 39
Early vascular ageing biomarkers in osteoporotic outpatients: a pilot study 39
Familiar osteopoikilosis: Case report with differential diagnosis and review of the literature 38
Quantitative ultrasound and DXA measurements in aromatase inhibitor-treated breast cancer women receiving denosumab 36
Pathogenesis of Thalassemia Major-Associated Osteoporosis: Review of the Literature and Our Experience 36
Sclerostin is a possible candidate marker of arterial stiffness: Results from a cohort study in Catania 36
Anxiety levels predict bone mineral density in postmenopausal women undergoing oral bisphosphonates: A two-year follow-up 32
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 32
Vitamin d boosts alendronate tail effect on bone mineral density in postmenopausal women with osteoporosis 26
null 21
null 21
POS1119 A SINGLE DOSE OF ZOLEDRONATE INDUCES MODIFICATIONS OF SERUM VEGF IN OSTEOPOROTIC POSTMENOPAUSAL WOMEN 17
IMPACT OF ANXIETY LEVELS ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN TREATED WITH ORAL BIPHOSPHONATES: RESULTS FROM A LONGITUDINAL COHORT STUDY 16
Osteoporosis and Fragility Fractures in Type 2 Diabetes 14
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 11
Clinical and molecular description of the first Italian cohort of 33 subjects with hypophosphatasia 7
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 6
Totale 2.408
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.957
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.957
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020236 0 0 5 22 4 28 47 32 5 57 33 3
2020/2021207 24 1 64 8 16 30 1 20 0 17 19 7
2021/2022422 1 63 14 7 14 7 49 13 32 79 36 107
2022/2023959 63 110 51 53 79 95 11 63 385 12 23 14
2023/2024302 20 39 16 29 15 81 3 39 0 11 14 35
2024/202560 29 21 10 0 0 0 0 0 0 0 0 0
Totale 2.408